Skip Navigation



Hum. Reprod. Advance Access published online on March 16, 2006

Human Reproduction, doi:10.1093/humrep/del019
This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
21/6/1576    most recent
del019v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Boe-hansen, G. B.
Right arrow Articles by Christensen, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boe-hansen, G. B.
Right arrow Articles by Christensen, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received April 12, 2005
Revised January 6, 2006
Accepted January 13, 2006

Article

The sperm chromatin structure assay as a diagnostic tool in the human fertility clinic

Gry Brandt Boe-hansen 1 *, Jens Fedder 2, Annette Kjær Ersbøll 3, and Preben Christensen 1

1 Department of Large Animal Sciences, Section for Veterinary Reproduction & Obstetrics, The Royal Veterinary & Agricultural University, Frederiksberg C, Denmark
2 The Fertility Clinic and The Scientific Unit, Brædstrup Hospital, Brædstrup
3 Department of Large Animal Sciences, Section for Population Biology, The Royal Veterinary and Agricultural University, Frederiksberg C, Denmark

* To whom correspondence should be addressed.
Gry Brandt Boe-hansen, E-mail: gbh{at}kvl.dk


   Abstract

BACKGROUND: Sperm DNA integrity has been shown to be necessary for achieving and sustaining embryo development. The objective was to evaluate the sperm chromatin structure assay (SCSA) as a diagnostic tool in clinical practice for intrauterine insemination (IUI), in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatments. METHODS: A total of 385 semen samples from 234 couples were frozen for SCSA, and smears were prepared for morphology: 48 IUI, 139 IVF and 47 ICSI. The main SCSA variables were DNA fragmentation index (DFI), standard deviation of DFI (SD-DFI) and high DNA stainability (HDS), and the reproductive outcomes were biochemical pregnancy (BP), clinical pregnancy (CP) and implantation ratio (IR). RESULTS: The results showed no significant difference in the fertility variables BP, CP and IR when <27% DFI was used between the IVF and ICSI groups. A low number of patients received IUI with low success rate, and statistical analysis was therefore not performed. Ongoing pregnancy was achieved for both IVF and ICSI couples with DFI levels >27%, and six couples in ICSI treatment achieved CP full-term. DFI >27% had a high prognostic power for predicting no CP for IVF patients, with a specificity of 97%. Couples diagnosed with male infertility had a significantly higher level of DFI compared to couples with idiopathic fertility. Sperm head morphology showed low but significant correlations with the SCSA variables. CONCLUSION: SCSA is a useful tool in andrological diagnosis and contributes with a prognosis for the fertility outcome of conventional IVF. Although full-term pregnancy can be achieved with assisted reproductive techniques with a DFI >27%, the probability of a successful pregnancy may be reduced.

Keywords: male infertility/morphology/pregnancy/sperm DNA fragmentation/spermatozoa.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J AndrolHome page
A. Zini and M. Sigman
Are Tests of Sperm DNA Damage Clinically Useful? Pros and Cons
J Androl, May 1, 2009; 30(3): 219 - 229.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
T. F. Wu and D. S. Chu
Sperm Chromatin: Fertile Grounds for Proteomic Discovery of Clinical Tools
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1876 - 1886.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
N. L. Brackett, E. Ibrahim, J. A. Grotas, T. C. Aballa, and C. M. Lynne
Higher Sperm DNA Damage in Semen From Men With Spinal Cord Injuries Compared With Controls
J Androl, January 1, 2008; 29(1): 93 - 99.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D.Y. Liu and H.W.G. Baker
Human sperm bound to the zona pellucida have normal nuclear chromatin as assessed by acridine orange fluorescence
Hum. Reprod., June 1, 2007; 22(6): 1597 - 1602.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.